Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 3Thoracic 1Sarcoma 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Sarcoma 286Gliosarcoma 149Glioblastoma 149Brain Neoplasms 90Osteosarcoma 84Glioma 68Gastrointestinal Stromal Tumors 68Rhabdomyosarcoma 65Lymphoma, Non-Hodgkin 59Astrocytoma 59Recurrence 57Dendritic Cell Sarcoma, Interdigitating 57Sarcoma, Ewing 55Neoplasms 54Precursor Cell Lymphoblastic Leukemia-Lymphoma 50Lymphoma 50Burkitt Lymphoma 49Central Nervous System Neoplasms 48Neuroblastoma 47Lymphoma, Large B-Cell, Diffuse 47Lymphoma, Follicular 46Neoplasm Metastasis 45Lymphoma, Mantle-Cell 45Leiomyosarcoma 44Oligodendroglioma 43Leukemia, Myeloid, Acute 43Liposarcoma 42Lymphoma, B-Cell, Marginal Zone 41Leukemia, Lymphocytic, Chronic, B-Cell 41Hodgkin Disease 41

Interventions

Modafinil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Nervous System Neoplasms × Sarcoma × Clear all
NCT01032200 2021-09-28

Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors

Wake Forest University Health Sciences

Phase 2 Completed
54 enrolled 14 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Cognition Disorders, Ependymoma, Fatigue, Glioblastoma, Glioma, Meningioma, Nervous System Neoplasms, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡